Aspire Bariatrics withdraws AspireAssist from the market as COVID takes its toll
Aspire Bariatrics is closing all operations and, as a consequence, is withdrawing the controversial AspireAssist from the market,...
Aspire Bariatrics withdraws AspireAssist from the market as COVID takes its toll
NICE recommends semaglutide for obesity treatment
GI Dynamics gains approval to begin I-STEP clinical study in India
FDA approves Phase II trial for obesity-treating drug pemvidutide
RSIP Vision releases supporting technology for intraoperative video analysis
Endo Tools Therapeutics' endomina suturing tool gains FDA approval
Novo Nordisk to enter RNA market with Dicerna purchase
Bari Life introduces all-in-one bariatric supplement
Saxenda approved for the treatment of obesity in adolescents
EndoGastric Solutions launches GERDHelp Mobile App to assist GERD patients